PIK3CA and prostate carcinoma: Activating mutations in PIK3CA oncogene are found in around 30% of different tumors, including breast, colon, endometrium and prostate carcinomas [119]. AKT1 mutations were described in breast, colorectal, ovarian and endometrial carcinomas and cause AKT1 constitutive activation [120].